Nebenwirkungen · Neupro
Neupro 2 mg/24 h transdermal patch · Abschnitt 4.8 · PDF-Seite 24–25
HOS-114705 · Präparat HOS-094135
24 Nervous system Somnolence, Disturbances in Convulsion Dropped head disorders dizziness, consciousness syndromec,e headache NECa (incl. syncope, syncope vasovagal, loss of consciousness), dyskinesia, dizziness postural, lethargy Eye disorders Vision blurred, visual impairment, photopsia Ear and Vertigo labyrinth disorders Cardiac Palpitations Atrial fibrillation Supraventricular disorders tachycardia Vascular Orthostatic Hypotension disorders hypotension, hypertension Respiratory, Hiccups thoracic and mediastinal disorders Gastrointestinal Nausea, Constipation, Abdominal pain Diarrhoeac disorders vomiting dry mouth, dyspepsia Skin and Erythema, Pruritus Rash subcutaneous hyperhidrosis, generalised, skin generalised tissue disorders pruritus irritation, dermatitis contact Reproductive Erectile system and dysfunction breast disorder General Application and Oedema Irritability disorders and instillation site peripheral, administration reactionsa (incl. asthenic site conditions erythema, conditionsa pruritus, (incl. fatigue, irritation, rash, asthenia, dermatitis, malaise) vesicles, pain, eczema, inflammation, swelling, discolouration, papules, exfoliation, urticaria, hypersensitivity)
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-04-07T15:00:00Z · SHA-256 8c1c13f4377b291e92778d0cf7bf84640db85e338315a5f9bf30e0c0a33c9a3d · Passage 88abf8d0af1d5f6e99efc9050f14eef9ef0a5984e40fa5fc244b5e772dcf432a · Zeichen 14174–17079 im Abschnitt